Xiaohu Ding Selected Research

Xiaohu Ding Research Topics

4	Myopia 10/2021 - 10/2017
3	Cataract (Cataracts) 01/2021 - 11/2018
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 02/2015
1	Uveitis 01/2022
1	Toxocariasis 01/2022
1	Corneal Injuries 10/2021
1	Disease Progression 01/2021
1	Genetic Risk Score 01/2021
1	Atrophy 12/2019
1	Ocular Hypertension (Glaucoma, Suspect) 12/2019
1	Retinal Diseases 01/2019
1	Refractive Errors (Refractive Error) 01/2019
1	Blindness (Hysterical Blindness) 01/2019
1	Vision Disorders (Hemeralopia) 01/2019
1	Hyperopia (Hypermetropia) 01/2019
1	Familial Exudative Vitreoretinopathies 11/2018
1	Macular Degeneration (Age-Related Maculopathy) 01/2018
1	Retinal Perforations 10/2017
1	Retinal Detachment (Retinal Detachments) 10/2017
1	Benign essential blepharospasm 01/2016
1	Blepharospasm 01/2016
1	Glaucoma 01/2014
1	Low Tension Glaucoma 01/2014

5	Retinaldehyde (Retinal)IBA 01/2021 - 01/2018
3	Mydriatics (Cycloplegics)IBA 10/2021 - 02/2015
2	Capsules (Microcapsules)IBA 01/2019 - 11/2018
1	Interleukin-13IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	CytokinesIBA 01/2022
1	Interleukin-5 (Interleukin 5)IBA 01/2022
1	Ophthalmic Solutions (Eye Drops)IBA 10/2021
1	Hyaluronic Acid (Hyaluronan)IBA 10/2021
1	dimemorfan (AT 17)IBA 04/2021
1	ORALIT (ORS)IBA 01/2021
1	Dihydrotachysterol (AT 10)IBA 11/2020
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2019
1	Type A Botulinum Toxins (Botox)FDA Link 01/2016
1	incobotulinumtoxinA FDA Link 01/2016
1	Ginkgo biloba extract (Rokan)IBA 01/2014
1	N 30IBA 01/2014